Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessEvolv Technologies Holdings (NASDAQ: EVLV) Quarterly Earnings Preview

Evolv Technologies Holdings (NASDAQ: EVLV) Quarterly Earnings Preview

Add to Favorite
Added to Favorite


Analysts predict a loss of $0.06 per share with projected revenue of $26.4 million.
Significant leadership changes amid investigations into sales practices and revenue recognition issues.
Financial metrics reveal challenges but also investor confidence and stability in liquidity.

Evolv Technologies Holdings (NASDAQ: EVLV) is gearing up to unveil its quarterly earnings on December 5, 2024. Analysts are forecasting the company to report a loss of $0.06 per share, alongside anticipated revenue of approximately $26.4 million. EVLV operates within the competitive security screening technology sector, rivaling entities such as Smiths Detection and Rapiscan Systems.

Recent times have seen EVLV undergo notable leadership transitions. The departure of CFO Mark Donohue, who will part ways without severance, succeeded the dismissal of the CEO. These shifts are tied to ongoing probes into the firm’s sales methodologies and issues with improper revenue acknowledgment, as evidenced by the company’s delay in filing its quarterly report punctually.

The financial indicators of EVLV mirror its present hurdles. The company’s negative price-to-earnings (P/E) ratio stands at -35.11, signaling persistent losses. However, the price-to-sales ratio at 7.56 indicates that investors remain somewhat optimistic about EVLV’s future, willing to invest $7.56 for every dollar of sales. The enterprise value to sales ratio is marginally lower at 7.18, whereas the enterprise value to operating cash flow ratio is negative at -16.33, underscoring the company’s struggle in fostering positive cash flow. The negative earnings yield is at -2.85%, further accentuating EVLV’s financial predicaments.

Conversely, EVLV boasts a low debt-to-equity ratio of 0.011, indicating a minimal dependency on debt financing. Moreover, the current ratio of 1.74 portrays that the company possesses adequate liquidity to cover its short-term liabilities, offering a semblance of stability amidst its fiscal challenges.

Subscribe to get Latest News Updates

Latest News

You may like more
more

LightPath Technologies’ Price Target Raised to $4, Shares Gain 15 percent

LightPath Technologies (NASDAQ:LPTH) shares rose more than 15% intra-day...

MakeMyTrip Target Raised to $130 Amid Steady Growth

BofA Securities analysts increased their price target for MakeMyTrip...

The Bancorp Maintains Momentum with Extended REBL Property Sale Agreement

Piper Sandler analysts reaffirmed their Overweight rating and a...

Masimo’s Target Raised to $194 as Core Healthcare Focus Expected to Drive Growth

Raymond James analysts increased their price target for Masimo...